Intravascular Brachytherapy: Indications and Management of Adverse Events

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.6, 2004-01, pp. : 385-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 159-161

Karger

Access to resources Recommend Favorite

Transdermal Rivastigmine: Management of Cutaneous Adverse Events and Review of the Literature

By Greenspoon Jill Herrmann Nathan Adam David N.

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 575-583

Adis International

Access to resources Recommend Favorite

Adverse Events Reporting

By Adis International Limited

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 225-225

Adis International

Access to resources Recommend Favorite

Adverse drug events in outpatients

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK: An Observational Study

By Fogg Carole Kasliwal Rachna Shakir Saad A.W.

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 229-237

Adis International

Access to resources Recommend Favorite